🇺🇸 FDA
Patent

US 8183012

Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs

granted A61PA61P43/00A61P7/00

Quick answer

US patent 8183012 (Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs) held by The Regents of the University of California expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P43/00, A61P7/00